Tag: Quality Systems

Mapping the Root Causes of Bioburden Spikes in Pre-Filtration During Routine Environmental Monitoring Trending Bioburden spikes in pre-filtration during routine environmental monitoring (EM) present significant challenges for pharmaceutical manufacturers, particularly…

Addressing Filter Integrity Failures during Routine Environmental Monitoring: A Comprehensive Investigation Guide In the highly regulated environment of pharmaceutical manufacturing, the failure of filter integrity during routine environmental monitoring (EM)…

Understanding OOS Results for Particulate Matter in Environmental Monitoring Trends: A Structured Investigation Particulate matter (PM) unexpectedly flagged as out-of-specification (OOS) during routine environmental monitoring (EM) can cause significant concerns…

Aseptic Gowning Deviation during Terminal Sterilization: Assessing Risk and Ensuring Compliance In the highly regulated world of pharmaceutical manufacturing, maintaining sterility is critical, particularly during terminal sterilization processes. An aseptic…

Root Cause Analysis of Unplanned Line Stoppage After Sterile Filtration The pharmaceutical industry often faces challenges that can result in unplanned line stoppages during critical processes such as sterile filtration.…

Sterility Testing Failures during Aseptic Filling: Strategies for Data Integrity Checks Sterility test failures during aseptic filling present a significant challenge for pharmaceutical manufacturers, with implications that can ripple through…

Addressing Bioburden Spikes During Pre-Filtration Hold-Time Studies Bioburden spikes during pre-filtration hold-time studies can pose significant risks to the sterility and quality of parenteral drug products. These incidents may lead…